ISIN | LU0094557526 |
---|---|
Valor Number | 802705 |
Bloomberg Global ID | BBG000BHP5P3 |
Fund Name | MFS Meridian European Research A1 EUR |
Fund Provider |
MFS International Limited
London, United Kingdom Phone: +44 20 7429 7200 |
Fund Provider | MFS International Limited |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Carnegie Fund Services S.A. Genève 11 Phone: +41 22 705 11 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s objective is capital appreciation, measured in euros. The Fund invests primarily (at least 70%) in European equity securities. Some of the countries in Europe, primarily those in Eastern Europe, are currently considered emerging market economies. The Fund may invest in companies it believes to have above average earnings growth potential compared to other companies (growth companies), in companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. The Fund may invest in companies of any size. The Fund may invest a relatively large percentage of the Fund’s assets in a small number of countries and/or a particular geographic region. |
Peculiarities |
Current Price * | 49.63 EUR | 17.04.2025 |
---|---|---|
Previous Price * | 49.18 EUR | 16.04.2025 |
52 Week High * | 54.52 EUR | 28.02.2025 |
52 Week Low * | 46.92 EUR | 07.04.2025 |
NAV * | 49.63 EUR | 17.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 765,374,483 | |
Unit/Share Assets *** | 175,620,602 | |
Trading Information SIX |
YTD Performance | -2.19% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -3.35% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -7.19% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -4.30% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -4.95% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +0.57% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +5.06% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +6.80% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +40.63% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 3.75% | |
---|---|---|
Schneider Electric SE | 3.49% | |
ASML Holding NV | 3.46% | |
Nestle SA | 3.34% | |
Roche Holding AG | 3.00% | |
Lvmh Moet Hennessy Louis Vuitton SE | 2.92% | |
Linde PLC | 2.71% | |
Sanofi SA | 2.62% | |
Compagnie Financiere Richemont SA Class A | 2.20% | |
BNP Paribas Act. Cat.A | 2.11% | |
Last data update | 28.02.2025 |
TER *** | 0.25% |
---|---|
TER date *** | 31.07.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.05% |
Ongoing Charges *** | 1.97% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |